Conference
Pulmonary Complications in Patients Treated with Tyrosine Kinase Inhibitors, a Systematic Review and Meta-Analysis
Abstract
Abstract
Background: In patients with chronic myeloid leukemia (CML), long-term use of tyrosine kinase inhibitors (TKIs) is associated with hematological and non-hematological complications. To investigate the pulmonary complications (pulmonary edema and pulmonary arterial hypertension [PAH]) in CML patients receiving TKIs, we conducted a systematic review and meta-analysis of clinical trials and observational studies.
Authors
Chai-Adisaksopha C; Calvin D; Hillis CM
Volume
126
Publisher
American Society of Hematology
Publication Date
December 3, 2015
DOI
10.1182/blood.v126.23.4030.4030
Conference proceedings
Blood
Issue
23
ISSN
0006-4971